JA Stone
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Antifungal resistance and susceptibility 2
- HIV/AIDS drug development and treatment 2
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- J. M. Andrews (3 shared papers)Rik de Greef (2 shared papers)Tomoko Freshwater (2 shared papers)Malidi Ahamadi (2 shared papers)Jeroen Elassaiss‐Schaap (2 shared papers)JA Wagner (2 shared papers)Marian Iwamoto (2 shared papers)Marita Prohn (1 shared paper)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Journal of Clinical Pathology (1 paper)Postgraduate Medical Journal (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
JA Stone
12 papers receiving 531 citations
Peers
Comparison fields: 5 of 72
- Virology 140
- Infectious Diseases 233
- Molecular Medicine 41
- Oncology 201
- Pharmacology 92
Countries citing papers authored by JA Stone
This map shows the geographic impact of JA Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Stone more than expected).
Fields of papers citing papers by JA Stone
This network shows the impact of papers produced by JA Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Stone. The network helps show where JA Stone may publish in the future.
Co-authors
The 25 scholars most cited alongside JA Stone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 134 | |
| 2 | 2016 | 121 | |
| 3 | 2009 | 76 | |
| 4 | 2016 | 65 | |
| 5 | 1988 | 52 | |
| 6 | 1989 | 34 | |
| 7 | 1986 | 20 | |
| 8 | Drug interactions between caspofungin and tacrolimus | 2001 | 17 |
| 9 | 1986 | 16 | |
| 10 | 1989 | 8 | |
| 11 | 1990 | 6 | |
| 12 | 1988 | 2 |
About JA Stone
JA Stone is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Oncology and Clinical Biochemistry, having authored 12 papers that have together received 551 indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antifungal resistance and susceptibility (2 papers), Pneumonia and Respiratory Infections (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), HIV/AIDS drug development and treatment (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Virology (140 citations), Infectious Diseases (233 citations), Molecular Medicine (41 citations), Oncology (201 citations) and Pharmacology (92 citations). JA Stone has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include J. M. Andrews, Rik de Greef, Tomoko Freshwater, Malidi Ahamadi, Jeroen Elassaiss‐Schaap, JA Wagner, Marian Iwamoto, Marita Prohn, Anna Kondic and Chang Li. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacology & Therapeutics, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Clinical Pathology and Postgraduate Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.